What's breaking now, across thousands of outlets.
Novartis’ $12 billion acquisition of Avidity Biosciences “remains absolutely on track,” CEO Vas Narasimhan said, after the company disclosed a $1.9 billion impairment charge on a failed late-stage neuromuscular disease asset it ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Chief of Army Staff, Lt.-Gen. Waidi Shaibu, has warned Nigerian Army personnel against drug abuse and the stigma associated with mental health challeng Read More…
The top court criticised the delay in acting against companies allegedly continuing to use temporary Covid-era approvals.
The number of confirmed Ebola cases in Democratic Republic of Congo has risen above 10,000, government data showed on Tuesday, a milestone that coincides with growing fears the epidemic could spread…
MA Muhit says the government also aims to equip health workers with modern tools and strengthen dengue prevention
The ticketing platform and Great Hill Partners made bold bets during the pandemic that led to a splashy sale in 2025.
The measles resurgence exposes the U.S.' public health weaknesses, such as declining vaccination rates and waning trust in health institutions, experts say.
